Cargando…

Validation of the Khorana Score to Assess Venous Thromboembolism and Its Association with Mortality in Cancer Patients: A Retrospective Community-based Observational Experience

Introduction: Khorana score (KS) stratifies patients into low, intermediate, and high risk groups for venous thromboembolism (VTE). We examined the generalizability of the KS to risk of VTE and association with mortality. Methods: A retrospective cohort study was conducted at Mount Auburn Hospital,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Gulrayz, Nasir, Hira Gulrayz, Hall, Kathryn, Weissmann, Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Preventive Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255532/ https://www.ncbi.nlm.nih.gov/pubmed/32489737 http://dx.doi.org/10.7759/cureus.7883

Ejemplares similares

Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
por: Akasaka-Kihara, Fumie, et al.
Publicado: (2021)

Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
por: Sanfilippo, Kristen M., et al.
Publicado: (2022)

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy
por: Overvad, Thure Filskov, et al.
Publicado: (2022)

Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
por: Rupa-Matysek, Joanna, et al.
Publicado: (2017)

Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
por: Guman, Noori A. M., et al.
Publicado: (2021)

Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer
por: Piver, Rachael N., et al.
Publicado: (2023)

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
por: Mulder, Frits I., et al.
Publicado: (2019)

Retrospective Cohort Study of Venous Thromboembolism Rates in Ambulatory Cancer Patients: Association With Khorana Score and Other Risk Factors
por: Austin, Keziah, et al.
Publicado: (2019)

Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignancies
por: Ramos-Esquivel, Allan, et al.
Publicado: (2022)

Aspirin Compared With Other Anticoagulants for Use as Venous Thromboembolism Prophylaxis in Elective Orthopaedic Hip and Knee Operations: A Narrative Literature Review
por: Olukoya, Olatomiwa, et al.
Publicado: (2021)

Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data
por: Tsubata, Yukari, et al.
Publicado: (2022)

Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index
por: Choi, Yeo Jin, et al.
Publicado: (2021)

OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients
por: López Jiménez, C., et al.
Publicado: (2021)

Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma
por: Vathiotis, Ioannis, et al.
Publicado: (2018)

Venous Thromboembolism Risk Score and Pregnancy
por: Raia-Barjat, Tiphaine, et al.
Publicado: (2022)

Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels
por: Khorana, Alok A., et al.
Publicado: (2020)

Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience
por: Mirza, Abu-Sayeef, et al.
Publicado: (2019)

Effectiveness of Transesophageal Echocardiography in Preventing Thromboembolic Complications Before Cardioversion: A Narrative Review
por: Jain, Prateek, et al.
Publicado: (2023)

Pulmonary Tuberculosis Versus Recurrent Chemotherapy-Induced Pneumonitis: A Clinical Dilemma
por: Ahmed, Gulrayz, et al.
Publicado: (2017)

The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study
por: Overvad, Thure F., et al.
Publicado: (2022)

Comparative Efficacy of Oral Apixaban and Subcutaneous Low Molecular Weight Heparins in the Treatment of Cancer-Associated Thromboembolism: A Meta-Analysis
por: Baloch, Maryam F, et al.
Publicado: (2023)

Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort Study
por: Morgenstern, Jose, et al.
Publicado: (2021)

Incidence, risk factors, and outcomes of central venous catheter‐related thromboembolism in breast cancer patients: the CAVECCAS study
por: Debourdeau, Philippe, et al.
Publicado: (2017)

Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real‐world evaluation
por: Baker, Hailey A., et al.
Publicado: (2018)

Association between the Khorana risk score and all-cause mortality in Japanese patients with gastric and colorectal cancer: A retrospective cohort study
por: Zhang, Yu-Feng, et al.
Publicado: (2023)

CAR T-cell therapy for secondary CNS DLBCL
por: Ahmed, Gulrayz, et al.
Publicado: (2021)

Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial
por: Barni, Sandro, et al.
Publicado: (2020)

Using Injury Severity Score and Abbreviated Injury Score to Determine Venous Thromboembolism Risk
por: Hereford, Timothy, et al.
Publicado: (2019)

Development and validation of machine learning models for venous thromboembolism risk assessment at admission: a retrospective study
por: Sheng, Wenbo, et al.
Publicado: (2023)

Corrigendum to “Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial”
Publicado: (2020)

Socioeconomic Determinants of COVID-19 Incidence and Mortality in Florida
por: Backer, Sean, et al.
Publicado: (2022)

Circulating D-Dimers Increase the Risk of Mortality and Venous Thromboembolism in Patients With Lung Cancer: A Systematic Analysis Combined With External Validation
por: Li, Jing, et al.
Publicado: (2022)

Interventions in Maternal Anaemia to Reduce Maternal Mortality Rate Across India
por: Totade, Manisha, et al.
Publicado: (2023)

Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study
por: Dibiasi, Christoph, et al.
Publicado: (2022)

Pulmonary Manifestations at Different Stages in the Chronic Kidney Disease: An Observational Study
por: Parivakkam Mani, Anbumaran, et al.
Publicado: (2023)

Using Comorbidity Statistical Modeling to Predict Inpatient Mortality: Insights Into the Burden on Hospitalized Patients
por: Magacha, Hezborn M, et al.
Publicado: (2023)

Association Between Positive Troponin and Fear of Earthquakes: A Retrospective Study
por: Nabhan, Elias M, et al.
Publicado: (2023)

Resting heart rate and incident venous thromboembolism: the Multi-Ethnic Study of Atherosclerosis
por: Awotoye, Josephine, et al.
Publicado: (2020)

An Analysis of COVID-19 Mortality in Chhattisgarh: A Two-Year Study on Demographics, Trends, and Impacts
por: Agrawal, Sanjana, et al.
Publicado: (2023)

COVID-19 and Genitourinary Tract: A Retrospective Study in the Tertiary Care Center
por: Gupta, Rakesh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1iikgvvrm9ijmb8c6e1lhi3ra9